MPO can not only identify unstable plaques at an early stage, which is one of the inflammatory markers for the early diagnosis of acute coronary syndrome but also predict the future risk of cardiovascular disease independently, instead of relying on C-reactive protein and other inflammatory markers.
| Description | Type | Item NO | Source | Application | Recommend to use for |
| MPO-2A7 | mAb | GHMA059-1 | mouse | EIA, LF, Fluorescent | Labelling |
| MPO-2E9 | mAb | GHMA059-2 | mouse | EIA, LF, Fluorescent | Coating |
English
